TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8229903

Group type: EXPERIMENTAL
Intervention: Glucose drink in the morning
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repeated glucose containing drink to sustain high blood glucose levels for 2 hours
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Consumption of a glucose drink after overnight fasting
Number of subjects: 0
Study: 3511835

Group type: EXPERIMENTAL
Intervention: Doppler ultrasound
Number of subjects: 56

Group type: COMPARATOR
Intervention: Routine arteriography
Number of subjects: 56
Study: 31195867

Group type: EXPERIMENTAL
Intervention: Titrated oral solution of misoprostol
Number of subjects: 2

Group type: COMPARATOR
Intervention: Intravenous oxytocin
Number of subjects: 2
Study: 29874654

Group type: EXPERIMENTAL
Intervention: Ferric citrate hydrate
Number of subjects: 60

Group type: COMPARATOR
Intervention: Lanthanum carbonate (control)
Number of subjects: 60
Study: 26892845

Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 27

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 27
Study: 25044988

Group type: EXPERIMENTAL
Intervention: Low-fat, high-complex carbohydrate diet supplemented with long-chain n-3 PUFA (LFHCC n-3)
Number of subjects: 75
Study: 22561583

Group type: EXPERIMENTAL
Intervention: HFR‐Aequilibrium (HFR‐Aeq)
Number of subjects: 50

Group type: COMPARATOR
Intervention: HFR
Number of subjects: 50
Study: 20691040

Group type: COMPARATOR
Intervention: Conservative treatment (antibiotics, analgesics, and/or expectant management)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Elective resection of the affected colon segment (preferably laparoscopic)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Elective resection
Number of subjects: 214
Study: 18941533

Group type: EXPERIMENTAL
Intervention: Ortho All‐Flex Diaphragm, lubricant gel (Replens) and condoms
Number of subjects: 5045

Group type: COMPARATOR
Intervention: Condoms alone
Number of subjects: 5045

Group type: EXPERIMENTAL
Intervention: Ortho All‐Flex Diaphragm, lubricant gel (Replens) and condoms with consistent use
Number of subjects: 5045
Study: 16168735

Group type: EXPERIMENTAL
Intervention: Early-blind subjects
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sighted subjects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 12652226

Group type: EXPERIMENTAL
Intervention: Anecortave acetate 15 mg
Number of subjects: 128

Group type: COMPARATOR
Intervention: Anecortave acetate (other doses)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 11805185

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Cyclosporine (CsA)
Number of subjects: 84
Study: 10413912

Group type: EXPERIMENTAL
Intervention: Bassini technique
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Shouldice technique
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: McVay technique
Number of subjects: 119
Study: 9422185

Group type: EXPERIMENTAL
Intervention: Injured site tissue oxygenation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-injured site of fractured extremity
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-injured extremity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Post-day 4 oxygenation at both sites
Number of subjects: 0
Study: 2111249

Group type: EXPERIMENTAL
Intervention: PEEP-masks with 10 cm water pressure
Number of subjects: 47

Group type: COMPARATOR
Intervention: PEEP-masks with 0 cm water pressure (placebo)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (0 cm water pressure)
Number of subjects: 47
Study: 7457415

Group type: EXPERIMENTAL
Intervention: Diltiazem 120, 180, and 240 mg/day
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 6734694

Group type: EXPERIMENTAL
Intervention: metoprolol 100 to 200 mg/day
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: oxprenolol 120 to 240 mg/day
Number of subjects: 16
Study: 30170389

Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine patch
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Successful smoking cessation group (n=21)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: All subjects (after smoking cessation)
Number of subjects: 28
Study: 26503512

Group type: EXPERIMENTAL
Intervention: Pressure-Regulated Volume Control (PRVC) ventilation
Number of subjects: 11

Group type: COMPARATOR
Intervention: Conventional Pressure Control (PC) ventilation
Number of subjects: 11
Study: 24426817

Group type: EXPERIMENTAL
Intervention: Zolpidem-ER 12.5 mg (bedtime dosing)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Zaleplon 10 mg (middle-of-the-night dosing)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 22413805

Group type: EXPERIMENTAL
Intervention: Dornase alpha
Number of subjects: 33

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 33

Group type: COMPARATOR
Intervention: Hypertonic saline
Number of subjects: 33
Study: 20003568

Group type: EXPERIMENTAL
Intervention: 10 g AXOS per day for 3 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 18091290

Group type: EXPERIMENTAL
Intervention: Nurse case-managed intervention with incentives and tracking
Number of subjects: 520

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 520
Study: 16371019

Group type: EXPERIMENTAL
Intervention: In vivo purging with rituximab
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Ex vivo purging by CD34+ cell selection
Number of subjects: 27

Group type: COMPARATOR
Intervention: Unpurged patients
Number of subjects: 27
Study: 12741433

Group type: EXPERIMENTAL
Intervention: Fluconazole (800 mg loading dose, 200 or 400 mg daily maintenance dose depending on renal function)
Number of subjects: 110
Study: 11029368

Group type: EXPERIMENTAL
Intervention: Budesonide (BUD) 400 microgram twice daily
Number of subjects: 38
Study: 8812826

Group type: EXPERIMENTAL
Intervention: CATCH tobacco use intervention including the promotion of tobacco-free school policies
Number of subjects: 6527

Group type: EXPERIMENTAL
Intervention: CATCH tobacco use intervention
Number of subjects: 6527
Study: 1576648

Group type: EXPERIMENTAL
Intervention: Sodium valproate 400 mg B.I.d for eight weeks
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 4061530

Group type: EXPERIMENTAL
Intervention: Fetal biophysical profile
Number of subjects: 652

Group type: COMPARATOR
Intervention: Nonstress test
Number of subjects: 652
Study: 30971593

Group type: EXPERIMENTAL
Intervention: Terlipressin infusion at a dose of 2 μg/kg/h
Number of subjects: 0

Group type: COMPARATOR
Intervention: Norepinephrine infusion at a dose of 0.1 μg/kg/min
Number of subjects: 0
Study: 30407292

Group type: EXPERIMENTAL
Intervention: Clopidogrel and Aspirin
Number of subjects: 136

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 136
Study: 25600111

Group type: EXPERIMENTAL
Intervention: L-T4 treatment
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 25
Study: 24613271

Group type: EXPERIMENTAL
Intervention: Comprehensive care
Number of subjects: 252

Group type: COMPARATOR
Intervention: Interdisciplinary care
Number of subjects: 252

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 252
Study: 22266087

Group type: EXPERIMENTAL
Intervention: Unplugged intervention
Number of subjects: 1753
Study: 20636228

Group type: EXPERIMENTAL
Intervention: Sodium-restricted diet (2-3 g/day) and fluid restriction (1.5 L/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: General diet information on heart failure
Number of subjects: 30
Study: 18304952

Group type: EXPERIMENTAL
Intervention: Captopril (2 mg/kg/day, three doses a day)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Nifedipine (0.5 mg/kg/day, three doses a day)
Number of subjects: 40
Study: 15677832

Group type: EXPERIMENTAL
Intervention: High-guidance group (HG; two group sessions supervised by a physical therapist and one unsupervised home session per week, n = 17)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Medium-guidance group (MG; one supervised group session and two unsupervised home sessions per week, n = 16)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (C; no exercise, n = 16)
Number of subjects: 49
Study: 12898044

Group type: EXPERIMENTAL
Intervention: General anaesthesia
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Regional anaesthesia
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Nocturnal arterial oxygen saturation (SatO(2))
Number of subjects: 40
Study: 11860948

Group type: EXPERIMENTAL
Intervention: Immunization with HFRS vaccine
Number of subjects: 26419

Group type: EXPERIMENTAL
Intervention: Booster immunization after one year
Number of subjects: 26419
Study: 8970471

Group type: EXPERIMENTAL
Intervention: Prophylactic HIV-1 vaccine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Augmented designs for trials
Number of subjects: 0
Study: 1622173

Group type: EXPERIMENTAL
Intervention: Rifampin (600 mg orally every 8 h for the first 72 h and then every 12 h for a total of 10 days) plus a beta‐lactam agent plus an aminoglycoside
Number of subjects: 121

Group type: COMPARATOR
Intervention: Standard therapy of a beta‐lactam plus an aminoglycoside agent
Number of subjects: 121
Study: 6519163

Group type: EXPERIMENTAL
Intervention: Propranolol 120 mg orally
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Propranolol 10 mg intravenously
Number of subjects: 6
Study: 31288532

Group type: EXPERIMENTAL
Intervention: Endoscopic stapedotomy
Number of subjects: 64

Group type: COMPARATOR
Intervention: Conventional stapedotomy using operating microscope
Number of subjects: 64
Study: 30218805

Group type: EXPERIMENTAL
Intervention: Microsurgical resection alone
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Preoperative embolization followed by microsurgical resection
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Stereotactic radiosurgery alone
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Embolization followed by stereotactic radiosurgery
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Embolization alone
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 86
Study: 28655079

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemo‐radiotherapy
Number of subjects: 69

Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy only (CT)
Number of subjects: 69
Study: 25931658

Group type: EXPERIMENTAL
Intervention: Progressive resistance exercise training (PRET)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Standard therapeutic protocol (TP)
Number of subjects: 52
Study: 24026135

Group type: EXPERIMENTAL
Intervention: Voix d'Or(®) intervention
Number of subjects: 24

Group type: COMPARATOR
Intervention: Usual occupational activities (Control)
Number of subjects: 24
Study: 21378585

Group type: COMPARATOR
Intervention: Recombinant Factor VII (placebo-controlled)
Number of subjects: 347
Study: 18180244

Group type: EXPERIMENTAL
Intervention: ABVD regimen followed by involved field radiotherapy
Number of subjects: 181

Group type: COMPARATOR
Intervention: EVE regimen followed by involved field radiotherapy
Number of subjects: 181
Study: 16384692

Group type: EXPERIMENTAL
Intervention: B vitamins and soybean and fish oils supplementation
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (no supplementation)
Number of subjects: 61
Study: 16191248

Group type: EXPERIMENTAL
Intervention: Psychosocial intervention
Number of subjects: 0
Study: 11039963

Group type: EXPERIMENTAL
Intervention: Atraumatic needles
Number of subjects: 116

Group type: COMPARATOR
Intervention: Standard needles
Number of subjects: 116
Study: 8857476

Group type: EXPERIMENTAL
Intervention: Poloxamer-188 infusion for 48 hours
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Poloxamer-188 infusion
Number of subjects: 150
Study: 1346790

Group type: EXPERIMENTAL
Intervention: D1 agonist, piribedil, at 50‐100 mg/day, orally, for 8 weeks
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: D2 agonist, bromocriptine, at 2.5 ‐ 5 mg/day, orally, for another 8 weeks
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 6206718

Group type: EXPERIMENTAL
Intervention: Transfusion group (hemoglobin level kept above 10.0 g/dL)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Nontransfusion group (transfused only for specific clinical indications)
Number of subjects: 56
Study: 31662555

Group type: EXPERIMENTAL
Intervention: Good RTL group (low LTF1)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Moderate RTL group (high LTF1 and low LTF2)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Poor RTL group (high LTF1 and high LTF2)
Number of subjects: 92
Study: 29936464

Group type: EXPERIMENTAL
Intervention: Kyusho Jitsu intervention (24 weeks)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 51
Study: 25737191

Group type: EXPERIMENTAL
Intervention: Glycemic control
Number of subjects: 252

Group type: COMPARATOR
Intervention: Obesity
Number of subjects: 252
Study: 24231216

Group type: EXPERIMENTAL
Intervention: Duloxetine (60 mg/d), tamsulosin (0.4 mg/d), saw palmetto (320 mg/d)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Tamsulosin (0.4 mg/d), saw palmetto (320 mg/d)
Number of subjects: 38
Study: 22953318

Group type: COMPARATOR
Intervention: Metformin alone
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Rosiglitazone added to metformin
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: Metformin with family-based behavioural weight loss programme
Number of subjects: 699
Study: 19952577

Group type: EXPERIMENTAL
Intervention: Soccer training (SO, n = 19)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Running group (RU, n = 17)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (CON, n = 10)
Number of subjects: 36
Study: 17538890

Group type: EXPERIMENTAL
Intervention: 7-valent pneumococcal conjugate vaccine (PnCRM7)
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: 3-dose regimen for those 7-11 months of age
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: 2-dose regimen for those 12-23 months of age
Number of subjects: 610
Study: 15037536

Group type: EXPERIMENTAL
Intervention: Infliximab (anti-TNF-alpha therapy)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Standard treatment in combination with infliximab
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control subjects (age-matched)
Number of subjects: 14
Study: 11813591

Group type: EXPERIMENTAL
Intervention: ranitidine bismuth citrate b.i.d. co-prescribed with clarithromycin 250 mg q.i.d.
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: ranitidine bismuth citrate b.i.d. co-prescribed with clarithromycin 500 mg b.i.d.
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: ranitidine bismuth citrate b.i.d. co-prescribed with clarithromycin 500 mg b.i.d. plus metronidazole 400 mg b.i.d.
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: ranitidine bismuth citrate 400 mg b.i.d. for 14 days after initial treatment
Number of subjects: 648

Group type: COMPARATOR
Intervention: not applicable
Number of subjects: 648
Study: 9726701

Group type: EXPERIMENTAL
Intervention: Jet injection of midazolam at doses of 100, 150, and 200 microg/kg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intramuscular (i.m.) injection of midazolam at a dose of 80 microg/kg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Jet injection of midazolam at 200 microg/kg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Jet injection of midazolam
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Jet injection and i.m. injection of midazolam
Number of subjects: 40
Study: 9073056

Group type: EXPERIMENTAL
Intervention: Doxorubicin (A) 40 mg/m2 + Melphalan (M) 0.4 mg/kg + Cisplatin (C) 50 mg/m2
Number of subjects: 295

Group type: COMPARATOR
Intervention: Doxorubicin (A) 40 mg/m2 + Melphalan (M) 0.4 mg/kg
Number of subjects: 295
Study: 2309548

Group type: EXPERIMENTAL
Intervention: Ephedrine
Number of subjects: 16

Group type: COMPARATOR
Intervention: Fluid load (Control)
Number of subjects: 16
Study: 377433

Group type: EXPERIMENTAL
Intervention: Modified Makari skin test
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 30677629

Group type: EXPERIMENTAL
Intervention: Endoscopic microdebrider adenoidectomy (EMA)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Curettage adenoidectomy (CA)
Number of subjects: 60
Study: 26797134

Group type: EXPERIMENTAL
Intervention: Active beverage containing 361 mg of (poly)phenols and 120 mg of vitamin C, taken twice daily for 4 weeks
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Active beverage
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo (no polyphenol/vitamin C)
Number of subjects: 39
Study: 24362012

Group type: EXPERIMENTAL
Intervention: Hydration group (increased water intake by 1.0-1.5 L/day for 6 weeks)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (usual water intake)
Number of subjects: 29
Study: 21598839

Group type: EXPERIMENTAL
Intervention: Hypnosis with post-hypnotic suggestion
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (no hypnosis or suggestion)
Number of subjects: 56
Study: 19854321

Group type: EXPERIMENTAL
Intervention: Systemic corticosteroids (prednisone 50-100 mg equivalent)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nontapered 5- to 10-day course of corticosteroid therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combinations of oral and inhaled corticosteroids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral and intravenous corticosteroids, intramuscular and oral corticosteroid regimens
Number of subjects: 0

Group type: COMPARATOR
Intervention: Corticosteroid doses greater than standard doses
Number of subjects: 0
Study: 16932832

Group type: EXPERIMENTAL
Intervention: Former elite marathon runners
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (matched for age, gender and BMI)
Number of subjects: 20
Study: 15568599

Group type: EXPERIMENTAL
Intervention: Dobutamine infusion (10 microg/kg/min for 72 hours)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Standard therapy (digitalis, diuretics, ACE-inhibitors)
Number of subjects: 68
Study: 11737815

Group type: EXPERIMENTAL
Intervention: 1% hydrocortisone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.1% betamethasone-17-valerate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle cream (petrolatum)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated control
Number of subjects: 0
Study: 9357454

Group type: EXPERIMENTAL
Intervention: PTA plus medical treatment
Number of subjects: 62

Group type: COMPARATOR
Intervention: Medical treatment alone (control group)
Number of subjects: 62
Study: 1493945

Group type: EXPERIMENTAL
Intervention: Oral calcitriol (0.5 micrograms/day) for 8 weeks
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo (13 uremic HD patients and 12 healthy subjects)
Number of subjects: 31
Study: 3884905

Group type: EXPERIMENTAL
Intervention: cis-platinum
Number of subjects: 23

Group type: COMPARATOR
Intervention: cis-platinum plus hyaluronidase
Number of subjects: 23
Study: 30679283

Group type: EXPERIMENTAL
Intervention: government‐regulated rehabilitation guideline
Number of subjects: 340

Group type: COMPARATOR
Intervention: preferred‐provider insurance‐based rehabilitation
Number of subjects: 340

Group type: COMPARATOR
Intervention: education and activation by general practitioners
Number of subjects: 340

Group type: COMPARATOR
Intervention: general practitioner group
Number of subjects: 340

Group type: COMPARATOR
Intervention: preferred‐provider group
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: all groups
Number of subjects: 340
Study: 30672212

Group type: COMPARATOR
Intervention: Cervical plexus block (Control group)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Cervical plexus block combined with electroacupuncture (Observation group)
Number of subjects: 40
Study: 27336903

Group type: EXPERIMENTAL
Intervention: Microwave ablation (MWA) with continued EGFR-TKI
Number of subjects: 54

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: MWA (complete ablation)
Number of subjects: 54
Study: 24398786

Group type: EXPERIMENTAL
Intervention: Freeze-dried powdered yacon (FDY) containing 7.4 g of FOS
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 72
Study: 22500592

Group type: EXPERIMENTAL
Intervention: Freshly squeezed orange juice (n=10)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Freshly blended melon juice (n=10)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Freshly squeezed lime juice (n=10)
Number of subjects: 30
Study: 19846793

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 724

Group type: COMPARATOR
Intervention: Insulin
Number of subjects: 724

Group type: EXPERIMENTAL
Intervention: Metformin and/or Insulin
Number of subjects: 724
Study: 17902730

Group type: COMPARATOR
Intervention: 5% minoxidil applied twice daily
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Combined 5% minoxidil and 0.01% tretinoin applied once daily at night
Number of subjects: 31
Study: 16234763

Group type: EXPERIMENTAL
Intervention: Nebivolol (5-7.5 mg/day)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Atenolol (75-100 mg/day)
Number of subjects: 55
Study: 12098151

Group type: EXPERIMENTAL
Intervention: Normal condition (both limbs at 100 degrees of knee flexion)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Limb extended condition (dominant/uninvolved limb at 75 degrees of knee flexion)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Limb elevated condition (dominant/uninvolved limb on foam support equal to 25% of knee height)
Number of subjects: 20
Study: 10101621

Group type: EXPERIMENTAL
Intervention: High dose dynorphin A(1-13) (500 micrograms/kg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Low dose dynorphin A(1-13) (120 micrograms/kg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 7771420

Group type: EXPERIMENTAL
Intervention: Antireflux therapy (three types: two medical therapies and one surgical therapy)
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Subgroup of patients with abnormal baseline PFTs and healed esophagitis
Number of subjects: 247